Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer
Industry development with potential relevance for veterinary professionals, companion animal care, and animal health stakeholders.
Digital tools are becoming increasingly important across veterinary medicine, from clinical workflows to client communication and practice operations.
According to the announcement, Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer. The development is relevant because it reflects how animal health companies, service providers, and technology platforms are responding to changing expectations in veterinary care.
What Was Announced
ATLANTA, July 22, 2026 (GLOBE NEWSWIRE) -- Exubrion Therapeutics ® , the company behind Synovetin OA ® , has promoted Gregory Taglialatela, MBA, to Chief Commercial Officer, effective July 1, 2026. In his new role, Taglialatela will lead Exubrion's commercial strategy and execution, including national sales, key account management, business development, and strategic growth initiatives. He will be responsible for expanding access to Synovetin OA through veterinary treatment centers, strengthening customer and industry partnerships, and supporting the company’s growth, both nationally and abroad.
Synovetin OA is an injectable, localized treatment for canine osteoarthritis that treats inflammation within the affected joint and can provide up to one year of pain relief with a single treatment. Taglialatela brings more than 15 years of animal health experience and a proven track record of commercial leadership, strategic account development and partnership growth.
Why This Matters for Veterinary Professionals
For veterinary professionals, technology announcements matter when they affect efficiency, access to care, diagnostics, reimbursement, or the daily workflow of the clinic.
At the practice level, the most relevant question is whether the development can reduce administrative friction, improve access to information, or support more consistent communication between veterinary teams and clients.
Industry Perspective
The animal health industry continues to move toward more connected, data-driven services for veterinary practices and pet owners.
While individual announcements should be interpreted in the context of their source, they can help veterinary professionals monitor where investment, innovation, and market attention are moving across the animal health sector.
Original announcement: GlobeNewswire Veterinary Search — https://www.globenewswire.com/news-release/2026/07/22/3331339/0/en/exubrion-therapeutics-promotes-gregory-taglialatela-to-chief-commercial-officer.html
Comments
Related Articles
More news
Copyright © 2026 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment